Key Players
Competitive Landscape
Competition in neurocosmetic ingredients runs across three supplier groups. Givaudan, Croda and dsm-firmenich sell skincare actives with published clinical figures, and Symrise, IFF and Eurofragance build mood benefits around scent. Lubrizol competes with neuro and expression line peptides, Clariant through Lucas Meyer Cosmetics, and SkinBioTherapeutics through lysate science licensed to Croda. Clinical study depth and regional testing sites will shape supplier positions by 2036.
Launch activity picked up sharply in 2026, led by neuro claims from large ingredient groups. Givaudan unveiled PrimalHyal NeuroYouth in March 2026, and dsm-firmenich released Alpaflor Neurosooth in the same month [1] [2]. At in-cosmetics Global in April 2026, IFF presented MetaMood and MetaSleep, and Lubrizol presented the Eyeseryl All-In eye peptide [15] [18]. Eurofragance also introduced EuroMotion in April 2026, built on six emotion platforms identified from social listening [16]. Trade fairs will remain the main stage for new neuro claims aimed at brand owners.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| March 2026: Givaudan Active Beauty launched PrimalHyal NeuroYouth for Neuro Skin Ageing. | Anti-aging buyers want new mechanisms with clinical figures. | Nerve-based anti-aging claims are reaching premium serums. | Brands can relaunch serums with a new skin nerve claim. |
| March 2026: dsm-firmenich released Alpaflor Neurosooth, which received gold for Best Green Ingredient in April 2026. | Sensitive skin under heat stress needs calming actives. | Climate-adaptive soothing claims are spreading. | Natural soothing lines can reach sensitive-skin shoppers. |
| April 2026: IFF presented MetaMood and MetaSleep scent solutions. | Shoppers want mood and sleep support from daily products. | Fragrance houses are moving into neuro claims. | Body care and hair care can add mood benefits through scent. |
| April 2025: Croda launched Zenakine with measured happiness and sleep results. | Brands need wellbeing data next to skin data. | Wellbeing results are entering ingredient clinical files. | Night creams and scalp products can carry sleep and mood claims. |
Source: Future Market Insights, Neurocosmetic Ingredients Market Report, 2026-2036.
Givaudan and dsm-firmenich both sell skin-led neuro actives, and dsm-firmenich builds Alpaflor Neurosooth on Alpine botanical sourcing [2]. Croda stands apart through measured mood and sleep results from licensed lysate science [7]. Symrise, IFF and Eurofragance compete mainly on scent and emotion research.
Who leads the neurocosmetic ingredients market?
Leadership in neurocosmetic ingredients varies with the claim a brand wants to make. Givaudan backs PrimalHyal NeuroYouth with clinical studies on more than 120 volunteers [1]. Croda holds the clearest wellbeing results through Zenakine, and dsm-firmenich has placebo-controlled soothing data for Alpaflor Neurosooth [7] [2]. Supplier position will follow clinical proof, claim support in each market and the reach of testing sites.
Which companies have documented product-level evidence?
Givaudan, dsm-firmenich and Croda publish numeric clinical results for named neuro actives [1] [2] [7]. Symrise and IFF present mood benefits for Flowerconcentrole, MetaMood and MetaSleep through scent and consumer perception research [14] [15]. Actives with clinical figures on file should gain more formulas in Europe, as claims there need checkable proof [9].
What should buyers evaluate before approving a supplier?
Brand owners should check the study design, volunteer numbers, placebo controls and the dose tested before approving a neuro active. Natural origin data, local claim rules and nearby testing support also matter, and Lubrizol runs a testing centre in São Paulo for Brazilian brands [18]. Suppliers sharing full study files tend to gain approval from brands selling in several countries.
How is competition expected to change through 2036?
Fragrance houses bringing scent-based mood actives into skincare and body care will make the field more crowded. Acquisitions such as Clariant's purchase of Lucas Meyer Cosmetics may add more specialist active portfolios to large groups [8]. Suppliers with both skin and wellbeing data are expected to hold stronger pricing through 2036.
Representative Company Overview
| Company | Positioning | Recent Development |
|---|---|---|
| Givaudan | Neuro skin ageing actives | March 2026: PrimalHyal NeuroYouth unveiled with studies on more than 120 volunteers. |
| dsm-firmenich | Alpine botanical neuro actives | April 2026: Alpaflor Neurosooth received gold for Best Green Ingredient. |
| Croda | Lysate wellbeing actives | September 2025: Zenakine reported as available to customers worldwide. |
| Clariant | Specialty active portfolio | February 2026: Lucas Meyer Cosmetics reported growth driven by innovation. |
| Symrise | Mood botanical actives | April 2024: Flowerconcentrole launched with Actimood technology. |
| IFF | Scent mood solutions | April 2026: MetaMood and MetaSleep presented at in-cosmetics Global. |
| Lubrizol | Neuro and eye peptides | April 2026: Eyeseryl All-In presented at in-cosmetics Global. |
| Eurofragance | Emotion fragrance technology | April 2026: EuroMotion presented with six emotion platforms. |
| SkinBioTherapeutics | Lysate science licensing | June 2025: Zenakine commercial launch reported as progressing as expected. |
Research Methodology
Supplier selection covers companies with neuro-positioned launches, active ingredient portfolios, mood fragrance technology or lysate science between 2024 and 2026. Interviews took in ingredient suppliers, contract manufacturers, formulators and brand product developers. The desk review used company releases, clinical summaries, claim rules and trade press. Brand owners such as the Sisley Group and contract makers such as Gotha Cosmetics are covered as buyers of neuro actives.
